LV10046A - Preparats asinsvadu bojajumu profilaksei un arstesanai un piridoksala glutaminata 5'-fosfata magnija sals izmantosana asinsvadu bojajumu profilaksei un arstesanai - Google Patents

Preparats asinsvadu bojajumu profilaksei un arstesanai un piridoksala glutaminata 5'-fosfata magnija sals izmantosana asinsvadu bojajumu profilaksei un arstesanai

Info

Publication number
LV10046A
LV10046A LV930343A LV930343A LV10046A LV 10046 A LV10046 A LV 10046A LV 930343 A LV930343 A LV 930343A LV 930343 A LV930343 A LV 930343A LV 10046 A LV10046 A LV 10046A
Authority
LV
Latvia
Prior art keywords
treatment
damage prevention
vascular damage
glutaminate
pyridoxal
Prior art date
Application number
LV930343A
Other languages
English (en)
Other versions
LV10046B (en
Inventor
Werner Schneider
Britta Meyer
Erich F Elstner
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Publication of LV10046A publication Critical patent/LV10046A/lv
Publication of LV10046B publication Critical patent/LV10046B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LVP-93-343A 1990-05-25 1993-05-14 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions LV10046B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben

Publications (2)

Publication Number Publication Date
LV10046A true LV10046A (lv) 1994-05-10
LV10046B LV10046B (en) 1995-02-20

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-343A LV10046B (en) 1990-05-25 1993-05-14 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions

Country Status (28)

Country Link
US (1) US5372999A (lv)
EP (1) EP0458287B1 (lv)
JP (1) JPH07119174B2 (lv)
KR (1) KR970005180B1 (lv)
CN (1) CN1050750C (lv)
AT (1) ATE142884T1 (lv)
AU (1) AU651108B2 (lv)
CA (1) CA2043228C (lv)
CZ (1) CZ280683B6 (lv)
DE (2) DE4016963A1 (lv)
DK (1) DK0458287T3 (lv)
EG (1) EG19730A (lv)
ES (1) ES2091262T3 (lv)
GR (1) GR3021077T3 (lv)
HR (1) HRP931445B1 (lv)
HU (1) HU219223B (lv)
IE (1) IE76728B1 (lv)
IL (1) IL98156A (lv)
IN (1) IN173057B (lv)
LT (1) LT3335B (lv)
LV (1) LV10046B (lv)
MD (1) MD306C2 (lv)
MX (1) MX171883B (lv)
RU (1) RU2041713C1 (lv)
SI (1) SI9110925A (lv)
SK (1) SK278896B6 (lv)
UA (1) UA26973A1 (lv)
ZA (1) ZA913692B (lv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
JP2002539127A (ja) 1999-03-08 2002-11-19 メディキュア インコーポレーテッド ビタミンｂ−６障害のためのピリドキサル類縁体
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
WO2001013900A2 (en) 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
WO2001064692A1 (en) 2000-02-29 2001-09-07 Medicure International Inc. Cardioprotective phosphonates and malonates
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
RU2163132C1 (ru) * 2000-06-01 2001-02-20 Научно-исследовательский центр традиционной фитотерапии Способ лечения сердечно-сосудистых заболеваний фитопрепаратом и лекарственный сбор для лечения сердечно-сосудистых заболеваний
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
JP2004502757A (ja) 2000-07-07 2004-01-29 メディキュア　インターナショナル　インコーポレイテッド ピリドキシンおよびピリドキサール類縁体：心血管系治療薬
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
CA2585165A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (lv)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Also Published As

Publication number Publication date
IL98156A (en) 1996-06-18
CZ280683B6 (cs) 1996-04-17
HRP931445B1 (en) 2000-04-30
JPH04235130A (ja) 1992-08-24
MX171883B (es) 1993-11-22
IE76728B1 (en) 1997-11-05
ZA913692B (en) 1992-02-26
CA2043228C (en) 1998-07-14
MD306B1 (ro) 1995-10-31
CN1057391A (zh) 1992-01-01
SI9110925A (sl) 1998-06-30
EP0458287A3 (en) 1992-04-08
KR970005180B1 (ko) 1997-04-14
DE69122170D1 (de) 1996-10-24
HU219223B (en) 2001-03-28
EP0458287B1 (en) 1996-09-18
IL98156A0 (en) 1992-06-21
RU2041713C1 (ru) 1995-08-20
CS156391A3 (en) 1992-02-19
GR3021077T3 (en) 1996-12-31
SK278896B6 (sk) 1998-04-08
UA26973A1 (uk) 2000-02-28
MD306C2 (ro) 1996-02-29
IN173057B (lv) 1994-02-05
AU7730191A (en) 1991-11-28
LTIP580A (en) 1994-12-27
HRP931445A2 (en) 1996-02-29
EG19730A (en) 1996-01-31
AU651108B2 (en) 1994-07-14
US5372999A (en) 1994-12-13
HUT58204A (en) 1992-02-28
DE4016963A1 (de) 1991-11-28
DE69122170T2 (de) 1997-02-20
EP0458287A2 (en) 1991-11-27
ES2091262T3 (es) 1996-11-01
CN1050750C (zh) 2000-03-29
JPH07119174B2 (ja) 1995-12-20
LT3335B (en) 1995-07-25
HU911756D0 (en) 1991-12-30
ATE142884T1 (de) 1996-10-15
CA2043228A1 (en) 1991-11-26
LV10046B (en) 1995-02-20
IE911783A1 (en) 1991-12-04
DE4016963C2 (lv) 1992-04-30
DK0458287T3 (da) 1996-10-07
KR910019616A (ko) 1991-12-19

Similar Documents

Publication Publication Date Title
DK0458287T3 (da) Anvendelse af magnesium-pyridoxal-5-phosphat-glutaminat til forebyggelse af sygdomme forårsaget af vaskulære læsioner
NZ221424A (en) Pharmaceutical compositions contaipyrimidines
EP0534396A3 (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
ZA8993B (en) Medical treatment
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
DK0598365T3 (lv)
TW223589B (lv)
GR3006434T3 (lv)
CA2065889A1 (en) Increasing the choroidal blood flow
TW258733B (lv)
EP0316709A3 (en) Proteinaceous derivatives containing iron in highly bioaproteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical covailable form, preparation thereof and pharmaceutical compositions containing them mpositions containing them
GR3006610T3 (lv)
AU115540S (en) A component for a plough share